As of December 2024, Altimmune has a market cap of $443.26M. This makes Altimmune the world's 12364th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $487.05M | -19.42% |
2023 | $604.45M | -31.61% |
2022 | $883.84M | 79.59% |
2021 | $492.16M | -18.79% |
2020 | $606.06M | 496.83% |
2019 | $101.55M | -8.25% |
2018 | $110.68M | -96.55% |
2017 | $3.21B | - |